Literature DB >> 10981960

Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia.

A Hart1, F Melet, P Grossfeld, K Chien, C Jones, A Tunnacliffe, R Favier, A Bernstein.   

Abstract

The ETS gene Fli-1 is involved in the induction of erythroleukemia in mice by Friend murine leukemia virus and Ewings sarcoma in children. Mice with a targeted null mutation in the Fli-1 locus die at day 11.5 of embryogenesis with loss of vascular integrity leading to bleeding within the vascular plexus of the cerebral meninges and specific downregulation of Tek/Tie-2, the receptor for angiopoietin-1. We also show that dysmegakaryopoiesis in Fli-1 null embryos resembles that frequently seen in patients with terminal deletions of 11q (Jacobsen or Paris-Trousseau Syndrome). We map the megakaryocytic defects in 14 Jacobsen patients to a minimal region on 11q that includes the Fli-1 gene and suggest that dysmegakaryopoiesis in these patients may be caused by hemizygous loss of Fli-1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10981960     DOI: 10.1016/s1074-7613(00)00017-0

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  128 in total

Review 1.  Vascular potential of human pluripotent stem cells.

Authors:  Ionela Iacobas; Archana Vats; Karen K Hirschi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-05-07       Impact factor: 8.311

2.  Control of megakaryocyte-specific gene expression by GATA-1 and FOG-1: role of Ets transcription factors.

Authors:  Xun Wang; John D Crispino; Danielle L Letting; Minako Nakazawa; Mortimer Poncz; Gerd A Blobel
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

3.  Functional cross-antagonism between transcription factors FLI-1 and EKLF.

Authors:  Joëlle Starck; Nathalie Cohet; Colette Gonnet; Sandrine Sarrazin; Zina Doubeikovskaia; Alexandre Doubeikovski; Alexis Verger; Martine Duterque-Coquillaud; François Morle
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

Review 4.  Lonely in Paris: when one gene copy isn't enough.

Authors:  Ramesh A Shivdasani
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

5.  The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1.

Authors:  Berthold Göttgens; Cyril Broccardo; Maria-Jose Sanchez; Sophie Deveaux; George Murphy; Joachim R Göthert; Ekaterini Kotsopoulou; Sarah Kinston; Liz Delaney; Sandie Piltz; Linda M Barton; Kathy Knezevic; Wendy N Erber; C Glenn Begley; Jonathan Frampton; Anthony R Green
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

6.  Thrombocytopenia in mice lacking the carboxy-terminal regulatory domain of the Ets transcription factor Fli1.

Authors:  Omar Moussa; Amanda C LaRue; Romeo S Abangan; Christopher R Williams; Xian K Zhang; Masahiro Masuya; Yong Z Gong; Demetri D Spyropoulos; Makio Ogawa; Gary Gilkeson; Dennis K Watson
Journal:  Mol Cell Biol       Date:  2010-09-07       Impact factor: 4.272

Review 7.  The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis.

Authors:  Yoshihide Asano; Andreea M Bujor; Maria Trojanowska
Journal:  J Dermatol Sci       Date:  2010-07-03       Impact factor: 4.563

8.  Novel role for EKLF in megakaryocyte lineage commitment.

Authors:  Pilar Frontelo; Deepa Manwani; Mariann Galdass; Holger Karsunky; Felix Lohmann; Patrick G Gallagher; James J Bieker
Journal:  Blood       Date:  2007-08-22       Impact factor: 22.113

9.  Tescalcin is an essential factor in megakaryocytic differentiation associated with Ets family gene expression.

Authors:  Konstantin Levay; Vladlen Z Slepak
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

10.  FLI1 level during megakaryopoiesis affects thrombopoiesis and platelet biology.

Authors:  Karen K Vo; Danuta J Jarocha; Randolph B Lyde; Vincent Hayes; Christopher S Thom; Spencer K Sullivan; Deborah L French; Mortimer Poncz
Journal:  Blood       Date:  2017-04-21       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.